Tier 1 — highest

A Magtein®, Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults

Chengxiang Zhang, Qi Hu, Shifen Li, Feifei Dai, Wen Qian, Susan Hewlings, Ting Yan, Yubang Wang
Nutrients 2022 14(24):5235

Bibliography

PubMed
PMID 36558392
PubMed Central
PMC9786204
DOI
10.3390/nu14245235
Funding
Support is recorded from Wu-xi Magtein Bioscience, This research was funded by (Wu-xi Magtein Bioscience). See the original publication for grant and material-support details.
Competing interests
The authors report no relevant competing interests.

Study snapshot

DesignRandomized controlled clinical trial
ModelHuman participants
Sample109 healthy adults aged 18–65
InterventionMagteinPS multi-ingredient formula 2 g/day, containing magnesium L-threonate, phosphatidylserine and vitamins C/D, or placebo
Duration30 days
EndpointsClinical Memory Test domains; Overall memory quotient

What the study showed, in plain terms

This publication examines clinical memory test domains, overall memory quotient. Study population or evidence base: 109 healthy adults aged 18–65. Intervention or exposure: MagteinPS multi-ingredient formula 2 g/day, containing magnesium L-threonate, phosphatidylserine and vitamins C/D, or placebo.

Key findings

The multi-ingredient formulation improved memory-test performance compared with placebo across the measured domains.

What this study can and cannot tell us

Effects cannot be assigned to magnesium L-threonate alone because phosphatidylserine and vitamins were also present. Short-term test improvement is not proof of slower clinical cognitive decline.

Related papers in the corpus

Tier 1
Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Guosong Liu et al. · Journal of Alzheimer's disease : JAD · 2016
Tier 1
Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial
Heather A Hausenblas et al. · Sleep medicine: X · 2024
Tier 1
The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial
Adrian L Lopresti et al. · Frontiers in nutrition · 2026
Tier 1
Oral application of magnesium-L-threonate enhances analgesia and reduces the dosage of opioids needed in advanced cancer patients-A randomized, double-blind, placebo-controlled trial
Siyin Wu et al. · Cancer medicine · 2023
Tier 1
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery
Yuncheng Ni et al. · Breast cancer (Dove Medical Press) · 2023
Tier 3
Enhancement of learning and memory by elevating brain magnesium
Inna Slutsky et al. · Neuron · 2010

Citation network

Articles citing this research paper

2 articles

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Biohack Blueprint Research